Ligandrol (LGD-4033) and RAD140 (Testolone) are two potent SARMs combined to deliver a synergistic anabolic effect targeting muscle growth and strength. Developed in the early 2010s, LGD-4033 was initially intended to treat muscle wasting and osteoporosis by selectively binding to androgen receptors in muscle and bone. RAD140, on the other hand, was designed to provide steroid-like anabolic effects without severe androgenic side effects. The combination amplifies muscle-building effects while minimizing unwanted impacts, but it remains classified as a research compound with no formal medical approval.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about RAD & LGD by Spectre Labs, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.